Home/Filings/4/0001415889-24-005098
4//SEC Filing

Earnhardt Lisa D 4

Accession 0001415889-24-005098

CIK 0000001800other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:33 PM ET

Size

7.6 KB

Accession

0001415889-24-005098

Insider Transaction Report

Form 4
Period: 2024-02-21
Earnhardt Lisa
EXECUTIVE VICE PRESIDENT
Transactions
  • Award

    Common shares without par value

    2024-02-21+17,24092,677 total
  • Award

    Option (right to buy)

    2024-02-21+64,78764,787 total
    Exercise: $116.98From: 2025-02-21Exp: 2034-02-20Common Shares (64,787 underlying)
Footnotes (2)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 21,595 on February 21, 2025, 21,596 on February 21, 2026, and 21,596 on February 21, 2027.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001530893

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:33 PM ET
Size
7.6 KB